Ditchcarbon
  • Customers
  1. Organizations
  2. Coloplast
Public Profile
Medical Device Manufacturing
DK
updated 11 days ago

Coloplast

Company website

Coloplast A/S, a leading global healthcare company headquartered in Denmark (DK), specialises in innovative medical devices and services for individuals with intimate healthcare needs. Founded in 1957, Coloplast has established a strong presence in Europe, North America, and Asia, focusing on areas such as ostomy care, continence care, and wound and skin care. The company is renowned for its commitment to user-friendly products, including advanced ostomy bags and continence management solutions that enhance the quality of life for patients. Coloplast's dedication to research and development has positioned it as a market leader, with notable achievements in product innovation and patient support services. With a strong emphasis on sustainability and social responsibility, Coloplast continues to make significant strides in the healthcare industry, ensuring that individuals receive the best possible care.

DitchCarbon Score

How does Coloplast's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

54

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Coloplast's score of 54 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.

76%

Let us know if this data was useful to you

Coloplast's reported carbon emissions

In 2023, Coloplast A/S reported total greenhouse gas emissions of approximately 223,305,000 kg CO2e. This figure includes 17,514,000 kg CO2e from Scope 1 emissions, 31,427,000 kg CO2e from Scope 2 emissions, and a significant 205,708,000 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming to achieve a 100% reduction in absolute Scope 1 and 2 emissions by FY2030, using FY2019 as the baseline. Additionally, Coloplast is committed to sourcing 100% renewable electricity annually through 2025 and reducing Scope 3 emissions by 50% per product manufactured by FY2030. Coloplast's emissions intensity metrics for 2023 indicate a Scope 1 and 2 emission intensity of 0.0009 kg CO2e per DKK of revenue. The company has consistently reported emissions across all three scopes since 2019, demonstrating a commitment to transparency and accountability in its sustainability efforts. These targets align with the Science Based Targets initiative (SBTi) and reflect Coloplast's dedication to mitigating climate change impacts within the healthcare equipment and supplies sector. The company's headquarters is located in Denmark (DK).

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2007200820092010201120122017201820192020202120222023
Scope 1
15,000,000
00,000,000
00,000,000
00,000,000
00,000,000
0,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
36,404,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
7,398,000
0,000,000
00,000,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Coloplast's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Coloplast is in DK, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Coloplast is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Smith Plus Nephew

GB
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 9 hours ago

Boston Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Edwards Lifesciences

US
•
Computer and related services (72)
Updated 4 days ago

Getinge

SE
•
Health and social work services (85)
Updated 5 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Stryker

US
•
Health and social work services (85)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.10
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy